Mergers & Acquisitions
Filter News
Found 21,666 articles
-
RaySearch acquires the product DrugLog from Pharmacolog for chemotherapy quality assurance
2/9/2024
Through this agreement, RaySearch acquires full ownership of all rights to the product DrugLog for its application in the field of oncology, including the measuring device, calibration parameters, source code, as well as intellectual property rights.
-
Premier Radiology Services Announces Acquisition of NationalRad
2/8/2024
Premier Radiology Services, LLC is pleased to announce the acquisition of Specialists in Diagnostic Imaging, LLC.
-
Novo’s Catalent Acquisition Surprises Some Analysts, Raises Questions about Existing Contracts
2/7/2024
While analysts are bullish on Novo Holdings’ $16.5 billion acquisition of Catalent, they say it raises questions for companies that have contracted the CDMO for manufacturing. -
QSAM Biosciences Signs Definitive Agreement to be Acquired by Telix Pharmaceuticals
2/7/2024
QSAM Biosciences Inc. (OTCQB: QSAM) (“QSAM or the “Company”) has signed a definitive Agreement and Plan of Merger (the “Agreement”) providing for the acquisition of the Company by Telix Pharmaceuticals Limited (ASX: TLX) (“Telix”).
-
Telix Signs Agreement to Acquire QSAM Biosciences and Its Bone Cancer Targeting Platform
2/7/2024
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire QSAM Biosciences, Inc. (U.S. OTC: QSAM) and its lead investigational drug Samarium-153-DOTMP (153Sm-DOTMP). QSAM is a United States (U.S.) based company developing therapeutic radiopharmaceuticals for primary and metastatic bone cancer.
-
Jazz Pharmaceuticals Enters Definitive Agreement with Redx Pharma to Acquire Global Rights to KRAS Inhibitor Program
2/7/2024
Jazz Pharmaceuticals plc and Redx Pharma plc announced that the companies have signed a definitive agreement under which Jazz will acquire Redx's KRAS inhibitor program.
-
Bruker Acquires Nanophoton Corporation, a Japanese Technology Leader in Research Raman Microscopy with 20 Years of Experience
2/7/2024
Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems.
-
The Swiss pharma’s dealmaking momentum continues in early 2024 with the acquisition of German biotech MorphoSys in an effort to strengthen its oncology portfolio.
-
Immunome to Acquire AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala Pharmaceuticals
2/6/2024
Immunome, Inc. today announced that it entered into a definitive asset purchase agreement with Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, to acquire AL102.
-
Veracyte Completes Acquisition of C2i Genomics
2/6/2024
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced it has completed its acquisition of C2i Genomics, Inc., adding whole-genome minimal residual disease (MRD) capabilities to its novel diagnostics platform.
-
Bruker Acquires Spectral Instruments Imaging, the Performance Leader in Preclinical In-Vivo Optical Imaging Systems
2/6/2024
Bruker Corporation announced that it has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems.
-
The investment arm of the Novo Nordisk Foundation is acquiring contract development and manufacturing organization Catalent to help meet high demand for Ozempic and Wegovy.
-
Merck Animal Health to Acquire Elanco’s Aqua Business
2/5/2024
Merck Animal Health announced that it has signed a definitive agreement to acquire the aqua business of Elanco Animal Health Incorporated for $1.3 billion in cash, consisting of an innovative portfolio of medicines and vaccines, nutritionals and supplements for aquatic species.
-
Elanco Announces Sale of Aqua Business for $1.3 Billion
2/5/2024
Elanco Animal Health Incorporated announced it has entered into an agreement to sell its aqua business to Merck Animal Health for approximately $1.3 billion in cash, which represents approximately 7.4x the estimated 2023 revenue of the Elanco aqua business.
-
MorphoSys Enters into Business Combination Agreement to be Acquired by Novartis for € 2.7 Billion Equity Value
2/5/2024
MorphoSys AG announced the company entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG based on Novartis' intention to submit a voluntary public takeover offer for all outstanding MorphoSys no-par value bearer shares at an offer price of € 68.00 per share in cash.
-
Inovalon Acquires VigiLanz; a Leading Clinical Surveillance and Patient Safety SaaS and Data Company
2/5/2024
Inovalon , a leading provider of cloud-based software solutions empowering data-driven healthcare, today announced the acquisition of VigiLanz, an industry leading, rapidly growing SaaS-based clinical surveillance and patient safety software and data company.
-
Novo Holdings to Acquire Catalent
2/5/2024
Catalent, Inc. and Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, announced that they have entered into a merger agreement under which Novo Holdings will acquire Catalent in an all-cash transaction that values Catalent at $16.5 billion on an enterprise value basis.
-
Myriad Genetics Completes Acquisition of Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics
2/1/2024
Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced it has completed the acquisition from Intermountain Health of select assets from its Intermountain Precision Genomics (IPG) laboratory business, including the Precise™ Tumor Test, the Precise Liquid Test, and IPG’s CLIA-certified laboratory in St. George, Utah.
-
UCI Health Reaches Definitive Agreement to Acquire Four Southern California Hospitals From Tenet Healthcare Corporation
2/1/2024
The Regents of the University of California, on behalf of the University of California, Irvine, has entered into a definitive agreement with Tenet Healthcare Corporation to acquire Tenet's Pacific Coast Network.
-
RTI Surgical Completes Acquisition of Cook Biotech
2/1/2024
RTI Surgical, an industry leading contract development and manufacturing organization, serving the regenerative medicine industry, announced that it has completed its previously announced acquisition of Cook Biotech Incorporated.